Benjamin Halladay, CFO: Esperion Therapeutics ESPR Sell · Filed 25/09/18

Trade details

Type: Insider sale
Amount: $19,799.26
Shares · price: 7,046 sh · $2.81 a share
Held after: 474,862 sh
Stock: Esperion Therapeutics ESPR
Person: Benjamin HalladayCFO
Trade date: 25/09/17
Filed: 25/09/18
Days to filing: 1 days

Sold 1.5% of holdings

Share of holding sold: 1.5%

Esperion Therapeutics trades, last 26 weeks

What else happened in Esperion Therapeutics around then

Filed or reported within 30 days of the trade day · 25/08/18~25/10/17

Benjamin Halladay's recent trades

Benjamin HalladayCFO
SellEsperion Therapeutics
Sell
Esperion Therapeutics
ESPR
$34K
10,773 sh
$34K
Filed 06/18
Traded 06/17
Benjamin HalladayCFO
SellEsperion Therapeutics
Sell
Esperion Therapeutics
ESPR
$17.4K
6,424 sh
$17.4K
Filed 03/18
Traded 03/17
Benjamin HalladayCFO
SellEsperion Therapeutics
Sell
Esperion Therapeutics
ESPR
$26.9K
7,337 sh
$26.9K
Filed 25/12/18
Traded 25/12/17
Benjamin HalladayCFO
SellEsperion Therapeutics
Sell
Esperion Therapeutics
ESPR
$12
11 sh
$12
Filed 25/07/18
Traded 25/07/17
Benjamin HalladayCFO
SellEsperion Therapeutics
Sell
Esperion Therapeutics
ESPR
$8,313
7,229 sh
$8,313
Filed 25/06/18
Traded 25/06/17